Hasin DS, Sarvet AL, Meyers JL, et al. Epidemiology of adult DSM-5 major depressive disorder and its specifiers in the United States. JAMA Psychiatry. 2018;75(4):336–46. https://doi.org/10.1001/jamapsychiatry.2017.4602.

Article  PubMed  PubMed Central  Google Scholar 

GBD 2017 Disease and Injury Incidence and Prevalence Collaborators. Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet. 2017;392(10159):1789–858. https://doi.org/10.1016/s0140-6736(18)32279-7.

Article  Google Scholar 

American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 5th ed. Arlington: American Psychiatric Publishing; 2013.

Book  Google Scholar 

Franken IH, Rassin E, Muris P. The assessment of anhedonia in clinical and non-clinical populations: further validation of the Snaith–Hamilton Pleasure Scale (SHAPS). J Affect Disord. 2007;99(1–3):83–9. https://doi.org/10.1016/j.jad.2006.08.020.

Article  PubMed  Google Scholar 

Baune BT, Florea I, Ebert B, et al. Patient expectations and experiences of antidepressant therapy for major depressive disorder: a qualitative study. Neuropsychiatr Dis Treat. 2021;17:2995–3006. https://doi.org/10.2147/ndt.S325954.

Article  PubMed  PubMed Central  Google Scholar 

Arnaud AM, Brister TS, Duckworth K, et al. Impact of major depressive disorder on comorbidities: a systematic literature review. J Clin Psychiatry. 2022;83(6):43390. https://doi.org/10.4088/JCP.21r14328.

Article  Google Scholar 

Moitra M, Santomauro D, Degenhardt L, et al. Estimating the risk of suicide associated with mental disorders: a systematic review and meta-regression analysis. J Psychiatr Res. 2021;137:242–9. https://doi.org/10.1016/j.jpsychires.2021.02.053.

Article  PubMed  PubMed Central  Google Scholar 

Chesney E, Goodwin GM, Fazel S. Risks of all-cause and suicide mortality in mental disorders: a meta-review. World Psychiatry. 2014;13(2):153–60. https://doi.org/10.1002/wps.20128.

Article  PubMed  PubMed Central  Google Scholar 

McIntyre RS, Filteau M-J, Martin L, et al. Treatment-resistant depression: definitions, review of the evidence, and algorithmic approach. J Affect Disord. 2014;156:1–7. https://doi.org/10.1016/j.jad.2013.10.043.

Article  CAS  PubMed  Google Scholar 

Qaseem A, Barry MJ, Kansagara D, et al. Nonpharmacologic versus pharmacologic treatment of adult patients with major depressive disorder: a clinical practice guideline from the American College of Physicians. Ann Intern Med. 2016;164(5):350–9. https://doi.org/10.7326/M15-2570.

Article  PubMed  Google Scholar 

American Psychological Association. APA clinical practice guideline for the treatment of depression across three age cohorts. 2019. https://www.apa.org/depression-guideline/guideline.pdf. Accessed 18 Sept 2023.

US Department of Veterans Affairs. VA/DOD clinical practice guideline for the management of major depressive disorder. 2022. 4.0. https://www.healthquality.va.gov/guidelines/MH/mdd/VADoDMDDCPGFinal508.pdf. Accessed 18 Sept 2023.

Machado-Vieira R, Henter ID, Zarate CA Jr. New targets for rapid antidepressant action. Prog Neurobiol. 2017;152:21–37. https://doi.org/10.1016/j.pneurobio.2015.12.001.

Article  CAS  PubMed  Google Scholar 

Henter ID, Park LT, Zarate CA Jr. Novel glutamatergic modulators for the treatment of mood disorders: current status. CNS Drugs. 2021;35(5):527–43. https://doi.org/10.1007/s40263-021-00816-x.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Trivedi MH, Rush AJ, Wisniewski SR, et al. Evaluation of outcomes with citalopram for depression using measurement-based care in STAR*D: implications for clinical practice. Am J Psychiatry. 2006;163(1):28–40. https://doi.org/10.1176/appi.ajp.163.1.28.

Article  PubMed  Google Scholar 

Huynh NN, McIntyre RS. What are the implications of the STAR*D trial for primary care? A review and synthesis. Prim Care Companion J Clin Psychiatry. 2008;10(2):91. https://doi.org/10.4088/pcc.v10n0201.

Article  PubMed  PubMed Central  Google Scholar 

McIntyre RS, Alsuwaidan M, Baune BT, et al. Treatment-resistant depression: definition, prevalence, detection, management, and investigational interventions. World Psychiatry. 2023;22(3):394–412. https://doi.org/10.1002/wps.21120.

Article  PubMed  PubMed Central  Google Scholar 

Pigott HE, Kim T, Xu C, et al. What are the treatment remission, response and extent of improvement rates after up to four trials of antidepressant therapies in real-world depressed patients? A reanalysis of the STAR*D study’s patient-level data with fidelity to the original research protocol. BMJ Open. 2023;13(7): e063095. https://doi.org/10.1136/bmjopen-2022-063095.

Article  PubMed  PubMed Central  Google Scholar 

Gadad BS, Jha MK, Czysz A, et al. Peripheral biomarkers of major depression and antidepressant treatment response: current knowledge and future outlooks. J Affect Disord. 2018;233:3–14. https://doi.org/10.1016/j.jad.2017.07.001.

Article  CAS  PubMed  Google Scholar 

Orsolini L, Pompili S, Tempia Valenta S, et al. C-reactive protein as a biomarker for major depressive disorder? Int J Mol Sci. 2022;23(3):1616. https://doi.org/10.3390/ijms23031616.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Stahl SM. Dextromethorphan/bupropion: a novel oral nmda (N-methyl-d-aspartate) receptor antagonist with multimodal activity. CNS Spectr. 2019;24(5):461–6. https://doi.org/10.1017/S1092852919001470.

Article  PubMed  Google Scholar 

Sim K, Lau WK, Sim J, et al. Prevention of relapse and recurrence in adults with major depressive disorder: systematic review and meta-analyses of controlled trials. Int J Neuropsychopharmacol. 2016;19(2):pyv076. https://doi.org/10.1093/ijnp/pyv076.

Article  Google Scholar 

Burcusa SL, Iacono WG. Risk for recurrence in depression. Clin Psychol Rev. 2007;27(8):959–85. https://doi.org/10.1016/j.cpr.2007.02.005.

Article  PubMed  PubMed Central  Google Scholar 

Touya M, Lawrence DF, Kangethe A, et al. Incremental burden of relapse in patients with major depressive disorder: a real-world, retrospective cohort study using claims data. BMC Psychiatry. 2022;22(1):152. https://doi.org/10.1186/s12888-022-03793-7.

Article  PubMed  PubMed Central  Google Scholar 

Almohammed OA, Alsalem AA, Almangour AA, et al. Antidepressants and health-related quality of life (HRQOL) for patients with depression: analysis of the Medical Expenditure Panel Survey from the United States. PLoS One. 2022;17(4): e0265928. https://doi.org/10.1371/journal.pone.0265928.

Article  CAS  Google Scholar 

Saragoussi D, Christensen MC, Hammer-Helmich L, et al. Long-term follow-up on health-related quality of life in major depressive disorder: a 2-year European cohort study. Neuropsychiatr Dis Treat. 2018. https://doi.org/10.2147/NDT.S159276.

Article  PubMed  PubMed Central  Google Scholar 

IsHak WW, Mirocha J, James D, et al. Quality of life in major depressive disorder before/after multiple steps of treatment and one-year follow-up. Acta Psychiatr Scand. 2015;131(1):51–60. https://doi.org/10.1111/acps.12301.

Article  CAS  PubMed  Google Scholar 

Costanza A, Vasileios C, Ambrosetti J, et al. Demoralization in suicide: a systematic review. J Psychosom Res. 2022;157: 110788. https://doi.org/10.1016/j.jpsychores.2022.110788.

Article  PubMed  Google Scholar 

Berardelli I, Serafini G, Cortese N, et al. The involvement of hypothalamus–pituitary–adrenal (hpa) axis in suicide risk. Brain Sci. 2020;10(9):653. https://doi.org/10.3390/brainsci10090653.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Zhdanava M, Pilon D, Ghelerter I, et al. The prevalence and national burden of treatment-resistant depression and major depressive disorder in the United States. J Clin Psychiatry. 2021;82(2):29169. https://doi.org/10.4088/JCP.20m13699.

Article  Google Scholar 

Fava GA, Offidani E. The mechanisms of tolerance in antidepressant action. Prog Neuropsychopharmacol Biol Psychiatry. 2011;35(7):1593–602. https://doi.org/10.1016/j.pnpbp.2010.07.026.